Liposomal Bupivacaine and Bupivacaine for TTMPB in Median Sternotomy
Recruiting
N/A
Interventional Study
Median Sternotomy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 90
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 38 (estimated)
- Sponsor
- Tongji Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
In light of the ongoing controversy surrounding the efficacy of bupivacaine liposomes, our study was designed to investigate, for the first time, the differential postoperative analgesic effects between bupivacaine liposomes combined with bupivacaine hydrochloride and bupivacaine hydrochloride alone in transverse thoracic muscle plane block treatment. The aim is to provide evidence-based medical g…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients aged 18-90 years;
* ASA Class I \~ III;
* Patients undergoing elective median sternotomy.
Exclusion Criteria:
* Emergency surgery;
* Re-operation;
* Coagulation dysfunction;
* Preoperative left ventricular function was poor (ejection fraction \<35%);
* Systemic infe…
Contacts